This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for minor software changes.
Device | VENTANA PD-L1(SP142) Assay |
Generic Name | Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1 |
Applicant | VENTANA MEDICAL SYSTEMS, INC. |
Date Received | 2020-01-13 |
Decision Date | 2020-03-31 |
PMA | P160002 |
Supplement | S011 |
Product Code | PLS |
Advisory Committee | Pathology |
Supplement Type | Real-time Process |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | VENTANA MEDICAL SYSTEMS, INC. 1910 East Innovation Park Dr. tucson, AZ 85755 |
Supplement Number | Date | Supplement Type |
---|---|---|
P160002 | Original Filing | |
S019 | 2022-10-14 | 30-day Notice |
S018 | 2022-07-12 | 30-day Notice |
S017 | 2022-02-16 | Special (immediate Track) |
S016 | 2022-01-28 | 135 Review Track For 30-day Notice |
S015 | 2021-09-07 | Special (immediate Track) |
S014 | 2021-02-22 | Real-time Process |
S013 | 2020-08-26 | Real-time Process |
S012 | 2020-01-21 | Normal 180 Day Track |
S011 | 2020-01-13 | Real-time Process |
S010 | 2019-08-22 | Real-time Process |
S009 | 2018-09-14 | Panel Track |
S008 | ||
S007 | 2018-06-18 | Real-time Process |
S006 | 2018-06-14 | Normal 180 Day Track |
S005 | ||
S004 | ||
S003 | 2017-07-17 | 30-day Notice |
S002 | 2017-03-16 | Normal 180 Day Track No User Fee |
S001 | 2016-09-01 | Normal 180 Day Track No User Fee |